Loading…

Terumo has completed the acquisition of Quirem Medical, a Netherlands-based developer of microspheres for liver cancer treatment. Terumo paid $20 million upfront with up to $25 million in milestone payments by 2030.
“The acquisition of Quirem Medical further strengthens our business, expands on our manufacturing and clinical development activities, and complements our comprehensive suite of offerings to support our customers.”massdevice.com
Summarized from public sources; check the original articles before acting on it.